Shejuan An

2.1k total citations
35 papers, 1.5k citations indexed

About

Shejuan An is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shejuan An has authored 35 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 18 papers in Oncology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shejuan An's work include Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Research Studies (7 papers) and Colorectal Cancer Treatments and Studies (5 papers). Shejuan An is often cited by papers focused on Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Research Studies (7 papers) and Colorectal Cancer Treatments and Studies (5 papers). Shejuan An collaborates with scholars based in China, United States and Switzerland. Shejuan An's co-authors include Yi‐Long Wu, Xu‐Chao Zhang, Jin‐Ji Yang, Zhihong Chen, Jian Su, Xue‐Ning Yang, Qing Zhou, Zhi Xie, Hong‐Hong Yan and Asrar B. Malik and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Shejuan An

34 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shejuan An China 16 808 722 601 400 234 35 1.5k
Zehang Jiang China 10 534 0.7× 479 0.7× 723 1.2× 392 1.0× 365 1.6× 16 1.3k
Ramon Andrade de Mello Portugal 21 477 0.6× 565 0.8× 745 1.2× 314 0.8× 202 0.9× 89 1.4k
Rintaro Noro Japan 25 978 1.2× 811 1.1× 697 1.2× 531 1.3× 83 0.4× 95 1.8k
Kathryn E. Beckermann United States 23 898 1.1× 622 0.9× 920 1.5× 483 1.2× 679 2.9× 57 2.0k
Jianjie Zhu China 25 1.1k 1.3× 437 0.6× 864 1.4× 713 1.8× 526 2.2× 63 2.1k
Vanja Vaccaro Italy 15 491 0.6× 312 0.4× 780 1.3× 301 0.8× 188 0.8× 30 1.2k
Geny Piro Italy 25 808 1.0× 260 0.4× 684 1.1× 341 0.9× 260 1.1× 59 1.6k
Antonella Argentiero Italy 23 596 0.7× 326 0.5× 794 1.3× 427 1.1× 406 1.7× 48 1.6k
Hongjun Gao China 19 478 0.6× 449 0.6× 557 0.9× 348 0.9× 87 0.4× 72 1.1k
Puay Hoon Tan Singapore 18 597 0.7× 461 0.6× 484 0.8× 361 0.9× 249 1.1× 41 1.4k

Countries citing papers authored by Shejuan An

Since Specialization
Citations

This map shows the geographic impact of Shejuan An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shejuan An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shejuan An more than expected).

Fields of papers citing papers by Shejuan An

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shejuan An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shejuan An. The network helps show where Shejuan An may publish in the future.

Co-authorship network of co-authors of Shejuan An

This figure shows the co-authorship network connecting the top 25 collaborators of Shejuan An. A scholar is included among the top collaborators of Shejuan An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shejuan An. Shejuan An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McCord, Matthew, Wenxia Wang, Shejuan An, et al.. (2024). The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma. Neuro-Oncology. 27(3). 644–651. 2 indexed citations
2.
Huang, Tina, Jin Qi, Shejuan An, et al.. (2023). LIN28B and Let-7 in Diffuse Midline Glioma: A Review. Cancers. 15(12). 3241–3241. 6 indexed citations
3.
An, Shejuan, Jeannie M. Camarillo, Daphne Li, et al.. (2020). Histone tail analysis reveals H3K36me2 and H4K16ac as epigenetic signatures of diffuse intrinsic pontine glioma. Journal of Experimental & Clinical Cancer Research. 39(1). 261–261. 21 indexed citations
4.
Tu, Hai‐Yan, Ming Fu, Wen‐Zhao Zhong, et al.. (2018). Impact of menopausal status and HER-2/neu protein on efficacy of EGFR-TKI in EGFR mutant patients with non-small cell lung cancer. Journal of Cancer. 9(17). 2987–2993. 2 indexed citations
5.
Cheng, Kwong Tai, Shiqin Xiong, Zhiming Ye, et al.. (2017). Caspase-11–mediated endothelial pyroptosis underlies endotoxemia-induced lung injury. Journal of Clinical Investigation. 127(11). 4124–4135. 346 indexed citations
6.
Gong, Haixia, Shejuan An, Antonia Sassmann, et al.. (2016). PAR1 Scaffolds TGFβRII to Downregulate TGF-β Signaling and Activate ESC Differentiation to Endothelial Cells. Stem Cell Reports. 7(6). 1050–1058. 15 indexed citations
7.
Zhang, Xu‐Chao, Shejuan An, Zhihong Chen, et al.. (2016). Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines. PLoS ONE. 11(3). e0149370–e0149370. 63 indexed citations
8.
Li, Jincheng, Lynn Htet Htet Aung, Bo Long, et al.. (2015). miR-23a binds to p53 and enhances its association with miR-128 promoter. Scientific Reports. 5(1). 16422–16422. 41 indexed citations
9.
Huang, Ling, Shejuan An, Zhihong Chen, et al.. (2014). MET Expression Plays Differing Roles in Non–Small-Cell Lung Cancer Patients with or without EGFR Mutation. Journal of Thoracic Oncology. 9(5). 725–728. 29 indexed citations
10.
Su, Jian, Xu‐Chao Zhang, Shejuan An, et al.. (2014). Detecting the spectrum of multiplex gene mutations in non-small cell lung cancer by Snapshot assay. Chinese Journal of Cancer. 33(7). 346–50. 13 indexed citations
11.
Chen, Liang, Shejuan An, Xiaohui Tan, et al.. (2014). MicroRNA-21 Down-regulates Rb1 Expression by Targeting PDCD4 in Retinoblastoma. Journal of Cancer. 5(9). 804–812. 29 indexed citations
12.
Tan, Xiaohui, Jin Peng, Yebo Fu, et al.. (2014). miR-638 mediated regulation of BRCA1affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer. Breast Cancer Research. 16(5). 435–435. 105 indexed citations
13.
An, Shejuan, Qiu‐Xiong Lin, Zhihong Chen, et al.. (2012). Combinations of laminin 5 with PTEN, p-EGFR and p-Akt define a group of distinct molecular subsets indicative of poor prognosis in patients with non-small cell lung cancer. Experimental and Therapeutic Medicine. 4(2). 226–230. 10 indexed citations
14.
Nie, Qiang, Xue‐Ning Yang, Shejuan An, et al.. (2011). CYP1A1*2A polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI and its combined effects with EGFR intron 1 (CA)n polymorphism. European Journal of Cancer. 47(13). 1962–1970. 23 indexed citations
15.
An, Shejuan, Yi-Sheng Huang, Zhihong Chen, et al.. (2011). Posttreatment plasma VEGF levels may be associated with the overall survival of patients with advanced non-small cell lung cancer treated with bevacizumab plus chemotherapy. Medical Oncology. 29(2). 627–632. 17 indexed citations
16.
Cheng, Hua, Shejuan An, Song Dong, et al.. (2011). Molecular mechanism of the schedule-dependent synergistic interaction in EGFR-mutant non-small cell lung cancer cell lines treated with paclitaxel and gefitinib. Journal of Hematology & Oncology. 4(1). 5–5. 28 indexed citations
17.
Chen, Zhihong, Ailin Guo, Shejuan An, et al.. (2010). High resolution melting analysis for the rapid and sensitive detection of KRAS codon 12 and 13 mutations in colorectal cancer. Zhonghua jianyan yixue zazhi. 33(3). 209–212. 1 indexed citations
18.
Cheng, Hua, Shejuan An, Xu‐Chao Zhang, et al.. (2010). In vitro sequence-dependent synergism between paclitaxel and gefitinib in human lung cancer cell lines. Cancer Chemotherapy and Pharmacology. 67(3). 637–646. 52 indexed citations
19.
An, Shejuan, Zhihong Chen, Qiu‐Xiong Lin, et al.. (2009). The -271 G>A polymorphism of kinase insert domain-containing receptor gene regulates its transcription level in patients with non-small cell lung cancer. BMC Cancer. 9(1). 144–144. 20 indexed citations
20.
Wang, Kun, Qing Zhou, Ailin Guo, et al.. (2009). An Autologous Therapeutic Dendritic Cell Vaccine Transfected with Total Lung Carcinoma RNA Stimulates Cytotoxic T Lymphocyte Responses Against Non-Small Cell Lung Cancer. Immunological Investigations. 38(7). 665–680. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zehang Jiang Breakdown of academic impact, for papers by Ramon Andrade de Mello Breakdown of academic impact, for papers by Rintaro Noro Breakdown of academic impact, for papers by Kathryn E. Beckermann Breakdown of academic impact, for papers by Jianjie Zhu Breakdown of academic impact, for papers by Vanja Vaccaro Breakdown of academic impact, for papers by Geny Piro Breakdown of academic impact, for papers by Antonella Argentiero Breakdown of academic impact, for papers by Hongjun Gao Breakdown of academic impact, for papers by Puay Hoon Tan
Rankless by CCL
2026